ArticleInternational journal of biomedical imaging2025
Enhanced Brain Tumor Segmentation Using CBAM-Integrated Deep Learning and Area Quantification.
Article in International journal of biomedical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Brain Tumor Segmentation and Grading on MRI Using Deep Learning: A Systematic Literature Review and Benchmark-Driven Comparative Analysis.Diagnostics (Basel, Switzerland) · 2026Review
- A fully optimized deep learning framework for explainable and efficient kidney stone detection in computed tomography imaging.Abdominal radiology (New York) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumors are complex clinical lesions with diverse morphological characteristics, making accurate segmentation from MRI scans a challenging task. Manual segmentation by radiologists is time-consuming and susceptible to human error. Consequently, automated approaches are anticipated to accurately delineate tumor boundaries and quantify tumor burden, addressing these challenges efficiently. The presented work integrates a convolutional block attention module (CBAM) into a deep learning architecture to enhance the accuracy of MRI-based brain tumor segmentation. The deep learning network is built upon a VGG19-based U-Net model, augmented with depthwise and pointwise convolutions to improve feature extraction and processing efficiency during brain tumor segmentation. Furthermore, the proposed framework enhances segmentation precision while simultaneously incorporating tumor area measurement, making it a comprehensive tool for early-stage tumor analysis. Several qualitative assessments are used to assess the performance of the model in terms of tumor segmentation analysis. The qualitative metrics typically analyze the overlap between predicted tumor masks and ground truth annotations, providing information on the segmentation algorithms' accuracy and dependability. Following segmentation, a new approach is used to compute the extent of segmented tumor areas in MRI scans. This involves counting the number of pixels within the segmented tumor masks and multiplying by their area or volume. The computed tumor areas offer quantifiable data for future investigation and clinical interpretation. In general, the proposed methodology is projected to improve segmentation accuracy, efficiency, and clinical relevance compared to existing methods, resulting in better diagnosis, treatment planning, and monitoring of patients with brain tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.